The knockout of its gene increased the number of CD8+ T cells and effectively curbed the development of tumors, suggesting that the high expression of FGL‐1 in tumor cells may be an important mechanism by which tumors escape immune clearance and may contribute to the poor patient response to PD‐1 blockade therapies. This evidence concerns the gene CD8A and neoplasm.